FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine and pharmaceutical industry and represents therapeutic agent, based on amantadine sulphate, for reduction of glutamate-induced apoptosis and inhibition of NMDA-receptors for treating nervous system disorders, effects of craniocereberal injury and ischemic and hemorrhagic stroke, characterized by that it contains therapeutically effective amount of amantadine sulphate and cytidine 5'-diphosphocholine as active substance, as well as at least one auxiliary substance, selected from group consisting of stabilizers, prolongators, buffering additive solvents, fillers, preserving agents, ingredients are taken in certain ratio, wt%.
EFFECT: invention provides extending of range of products for reduction of glutamate-induced apoptosis and inhibition of NMDA-receptors for treating disorders of nervous system, effects of craniocereberal injury and ischemic and hemorrhagic stroke, increase of clinical effectiveness, stability at room temperature, long storage life, at least 3 years.
4 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| MEDICATION, PROVIDING NEURO-PROTECTIVE ACTION IN ACUTE PERIOD OF CRANIOCEREBRAL INJURY | 2009 |
|
RU2414901C2 |
| MEDICINAL AGENT OFFERING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTICONVULSANT EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2309745C2 |
| MEDICATION FOR TREATING CEREBRAL CIRCULATION DISORDERS AND BRAIN TRAUMAS | 2012 |
|
RU2554502C9 |
| MEDICINAL AGENT SHOWING MULTIFACTOR NEUROPROTECTIVE AND NOOTROPIC EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2318501C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CONSEQUENCES OF CRANIOCEREBRAL INJURY AND METHOD FOR PRODUCTION THEREOF (EMBODIMENTS) | 2018 |
|
RU2693633C1 |
| MEDICATION PRODUCING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTIAMNESTIC ACTION IN ACUTE PERIODE OF CRANIOCEREBRAL TRAUMA | 2009 |
|
RU2424802C2 |
| NEURORABILITATION AGENT BASED ON SODIUM 6-OXO-1-PHENYL-2-(PHENYLAMINO)-1,6-DIHYDROPYRIMIDINE-4-OLATE | 2018 |
|
RU2675694C1 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
| METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
